Goto

Collaborating Authors

 asia pacific market


ABBYY Acquires Pericom Singapore to Expand Footprint in Asia Pacific

#artificialintelligence

ABBYY, a Digital Intelligence company, announced it acquired Pericom Singapore, part of the Pericom Group, a leading solution provider based in Singapore. The acquisition strengthens ABBYY's presence in Asia Pacific following the opening of its Hong Kong office in 2019, long-established office in Japan, and a strong partner network throughout the region. Singapore ranks first in the Asian Digital Transformation Index and is considered the trading crossroads for innovations in cloud computing, artificial intelligence, data analytics and other technologies that span healthcare, security, energy, aviation, defense, smart cities and education. As more Asia Pacific executives look to accelerate their digital business initiatives post-COVID, including 84% of Singapore businesses who have increased their budgets, ABBYY's growing presence signifies its readiness to meet their digital transformation needs. "We have had many successful large-scale implementations in the Asia Pacific market working closely with our valuable partners and large system integrators," commented Ulf Persson, CEO of ABBYY.


Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End-user and Country - ResearchAndMarkets.com

#artificialintelligence

DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering. Asia-Pacific artificial intelligence (AI) in drug discovery market will grow by 33.2% over 2020-2026 with a total addressable market cap of $2.78 billion, owing to fast adoption of AI technology in pharmaceutical industry and drug development. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026. Highlighted with 34 tables and 53 figures, this 121-page report is based on a comprehensive research of the entire Asia Pacific AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.